Chlorpheniramine Maleate + Naphazoline HCl + Phenylephrine HCl + Menthol + CamphorThird Party Manufacturing in India

Chlorpheniramine Maleate + Naphazoline HCl + Phenylephrine HCl + Menthol + Camphor works through multi-receptor targeted pathways. Chlorpheniramine blocks H1 histamine receptors to halt allergy cascades; naphazoline and phenylephrine stimulate alpha-adrenergic receptors to constrict dilated conjunctival arterioles, reducing redness; while menthol and camphor stimulate cold-sensitive receptors to elicit an immediate cooling, desensitizing sensation. They act on these targets to help the body relieve ocular congestion and severe itching. Unlike single decongestants, it combines allergy relief with instant physical comfort. It is highly effective and well-tolerated for acute relief.

Therapeutic Uses

• Allergic Ocular Congestion: Formulated for quick relief from eye redness, watering, and severe itching due to seasonal allergies or pollen exposure.
• Environmental Irritation: Soothes eyes exposed to intensive smoke, dust, smog, and chemical glare, restoring normal ocular appearance.

Why Manufacturers Choose Chlorpheniramine Maleate + Naphazoline HCl + Phenylephrine HCl + Menthol + Camphor

Chlorpheniramine Maleate + Naphazoline HCl + Phenylephrine HCl + Menthol + Camphor third party manufacturing in India is a dominant commercial force within the consumer OTC eye-care segment due to its immediate visual and sensory results. Celesta coordinates large-scale production via high-capacity partner facilities that are WHO-GMP certified, maintaining strict chemical uniformity and precise sterile preservation. This multi-ingredient product maximizes brand loyalty through instant patient satisfaction under certified WHO-GMP manufacturing conditions.